07:00 , Sep 19, 2011 |  BC Week In Review  |  Company News

Abcam, Ascent Scientific deal

Abcam acquired fellow reagent supplier Ascent for £10 million ($15.8 million) comprising £6 million ($9.5 million) in cash and £4 million ($6.3 million) in Abcam shares issued at 345.6p per share. Ascent had product revenues...
07:00 , Sep 8, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Clostridium Dynamin (DMN) Mouse and cell culture studies suggest the DMN inhibitor dyngo-4a could help prevent botulism. In cultured mouse hippocampal neurons, dyngo-4a pretreatment...